# Protalix BioTherapeutics, Inc.: Form 8-K/A, filed Oct 23, 2020

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K/A
- Filed: 2020-10-23
- Accepted by EDGAR: Oct 23, 2020, 17:01 ET
- Period: 2020-06-07
- Accession: 0001558370-20-011697
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837020011697/plx-20200607x8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837020011697/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837020011697/plx-20200607x8ka.htm

Filed Oct 23, 2020.
Source: SEC EDGAR, the filing index for accession 0001558370-20-011697. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
